---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-071031"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2023-08-28T23:59:59+00:00"
generated_at: "2026-06-11T03:08:05.453282+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Denali SPAC Holdco secures $18M Series A Preferred investment from FutureTech Capital for business combination

## Summary
- FutureTech Capital commits to purchase 1.8M shares of Series A Convertible Preferred Stock at $10/share ($18M total).
- Closing contingent on concurrent consummation of business combination with Longevity Biomedical.
- Preferred stock convertible into common at lower of $8.00 or 80% of 20-day VWAP, with $5.00 floor conversion price.
- Holders vote with common on as-converted basis and receive dividends as paid on common shares.
- Post-combination entity expected to list on Nasdaq as LBIO.

## SEC filing metadata
- accession: 0001213900-23-071031
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2023-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390023071031/0001213900-23-071031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390023071031/ea184258-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-071031
- JSON: https://secwatch.observer/filing/0001213900-23-071031.json
- Plain text: https://secwatch.observer/filing/0001213900-23-071031.txt

## Key facts
- Material Agreements
  Semnur Pharmaceuticals, Inc. entered into Subscription Agreement with FutureTech Capital LLC valued at 1,800,000 shares of Series A Convertible Preferred Stock at $10.00 per share (effective 2023-08-23).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: FutureTech Capital LLC
  - Value: 1,800,000 shares of Series A Convertible Preferred Stock at $10.00 per share
  - Effective: 2023-08-23
  source text: On August 23, 2023, Denali SPAC Holdco, Inc., (the “Company”), a subsidiary of Denali Capital Acquisition Corp. (“Denali”), entered into a Subscription Agreement (the “Subscription Agreement”) with FutureTech Capital LLC (the “Investor”), pursuant to which, among other things, the Investor agreed to subscribe for and purchase, and the Company agreed to issue and sell to the Investor, 1,800,000 shares of the Company’s Series A Convertible Preferred Stock, par value $0.0001 per share (the “Preferred Stock”), at a purchase price equal to $10.00 per share (the “Private Placement”) in connection with a financing effort related to the proposed business combination (the “Business Combination”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1913577/000121390023071031/0001213900-23-071031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.